These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16368991)

  • 1. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.
    Zhang MX; Bohlman MC; Itatani C; Burton DR; Parren PW; St Jeor SC; Kozel TR
    Infect Immun; 2006 Jan; 74(1):362-9. PubMed ID: 16368991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.
    Nishiya CT; Boxx GM; Robison K; Itatani C; Kozel TR; Zhang MX
    Infect Immun; 2016 Feb; 84(2):386-94. PubMed ID: 26573736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
    Boxx GM; Nishiya CT; Kozel TR; Zhang MX
    Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans.
    Zhang MX; Lupan DM; Kozel TR
    Infect Immun; 1997 Sep; 65(9):3822-7. PubMed ID: 9284158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.
    Zhang MX; Kozel TR
    Infect Immun; 1998 Oct; 66(10):4845-50. PubMed ID: 9746588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.
    Han Y; Kozel TR; Zhang MX; MacGill RS; Carroll MC; Cutler JE
    J Immunol; 2001 Aug; 167(3):1550-7. PubMed ID: 11466376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.
    Reiss E; de Repentigny L; Kuykendall RJ; Carter AW; Galindo R; Auger P; Bragg SL; Kaufman L
    J Clin Microbiol; 1986 Nov; 24(5):796-802. PubMed ID: 2429989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response that protects against disseminated candidiasis.
    Han Y; Cutler JE
    Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.
    Durandy A; Fischer A; Griscelli C
    J Clin Invest; 1983 Jun; 71(6):1602-13. PubMed ID: 6345586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
    Boxx GM; Kozel TR; Nishiya CT; Zhang MX
    Infect Immun; 2010 Mar; 78(3):1250-9. PubMed ID: 20028806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining criteria for anti-mannan antibodies to protect against candidiasis.
    Cutler JE
    Curr Mol Med; 2005 Jun; 5(4):383-92. PubMed ID: 15977994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.
    Jones JM
    Infect Immun; 1980 Oct; 30(1):78-89. PubMed ID: 7002793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
    Aydın C; Ataoğlu H
    Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.
    Kozel TR; MacGill RS; Percival A; Zhou Q
    Infect Immun; 2004 Jan; 72(1):209-18. PubMed ID: 14688098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species.
    Sendid B; Poirot JL; Tabouret M; Bonnin A; Caillot D; Camus D; Poulain D
    J Med Microbiol; 2002 May; 51(5):433-442. PubMed ID: 11990496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.
    Xin H
    Med Mycol; 2019 Aug; 57(6):745-756. PubMed ID: 30521033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis.
    Ifrim DC; Quintin J; Courjol F; Verschueren I; van Krieken JH; Koentgen F; Fradin C; Gow NA; Joosten LA; van der Meer JW; van de Veerdonk F; Netea MG
    J Interferon Cytokine Res; 2016 Apr; 36(4):267-76. PubMed ID: 27046240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.
    Matthews RC; Rigg G; Hodgetts S; Carter T; Chapman C; Gregory C; Illidge C; Burnie J
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2208-16. PubMed ID: 12821470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.